Cargando…

EHMTI-0202. Study protocol of BoTN: a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of botulinum toxin injections in the treatment of trigeminal neuralgia

Detalles Bibliográficos
Autores principales:	Burmeister, J, Holle, D, Bock, E, Ose, C, Diener, HC, Obermann, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180179/ http://dx.doi.org/10.1186/1129-2377-15-S1-C9

Ejemplares similares

Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial
por: Burmeister, Jan, et al.
Publicado: (2015)

EHMTI-0072. Anodal transcranial direct current stimulation alleviates pain in trigeminal neuralgia
por: Obermann, M, et al.
Publicado: (2014)

Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia
por: Kayani, Abdul Mueez Alam, et al.
Publicado: (2022)

Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up
por: Türk Börü, Ülkü, et al.
Publicado: (2017)

EHMTI-0138. Significance of neurovascular contact in classical trigeminal neuralgia
por: Maarbjerg, S, et al.
Publicado: (2014)

Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
por: Verma, Gaurav
Publicado: (2013)

Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases
por: Pearl, Craig, et al.
Publicado: (2022)

EHMTI-0240. Modulation of central pain processing by anodal direct current stimulation – a fMRI study
por: Naegel, S, et al.
Publicado: (2014)

EHMTI-0355. Comparison of carbamazepine and oxcarbazepine tolerability in patients with trigeminal neuralgia
por: Cregg, R, et al.
Publicado: (2014)

The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
por: Tereshko, Yan, et al.
Publicado: (2023)

Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
por: Shehata, Hatem S, et al.
Publicado: (2013)

Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort
por: Caldera, Manjula Chandragomi, et al.
Publicado: (2018)

The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review
por: Rubis, Anton, et al.
Publicado: (2020)

Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia
por: Hagenacker, Tim, et al.
Publicado: (2014)

Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review
por: Hu, Yong, et al.
Publicado: (2013)

Botulinum Toxin for Refractory Trigeminal Neuralgia: A Trial Sequential Analysis of Randomized Clinical Trials
por: Sridharan, Kannan, et al.
Publicado: (2018)

Pain Lateralization in Trigeminal Neuralgia
por: Obermann, Mark
Publicado: (2012)

Therapeutic effect of Botulinum toxin-A in 88 patients with Trigeminal Neuralgia with 14-month follow-up
por: Li, Shuang, et al.
Publicado: (2014)

Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia
por: Liu, Jing, et al.
Publicado: (2018)

Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect
por: Wu, Shouyi, et al.
Publicado: (2019)

EHMTI-0037. Botulinum A toxin for treatment of chronic migraine
por: Grazzi, L, et al.
Publicado: (2014)

EHMTI-0143. The association between stress and headache: a longitudinal population-based study
por: Schramm, S, et al.
Publicado: (2014)

EHMTI-0139. Field-testing of the ICHD-3 beta diagnostic criteria for classical trigeminal neuralgia
por: Maarbjerg, S, et al.
Publicado: (2014)

Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia
por: Wu, Chuanjie, et al.
Publicado: (2016)

Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia
por: Yoshida, Kazuya
Publicado: (2021)

Recent advances in understanding/managing trigeminal neuralgia
por: Obermann, Mark
Publicado: (2019)

Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study
por: Zhang, Haifeng, et al.
Publicado: (2017)

EHMTI-0124. Central vestibular system modulation in vestibular migraine - a VBM study
por: Wurthmann, S, et al.
Publicado: (2014)

EHMTI-0394. Predictive parameters for the effect of botulinum toxin infiltrations in chronic migraine
por: Bergmans, BA, et al.
Publicado: (2014)

Botulinum as a Toxin for Treating Post-herpetic Neuralgia
por: DING, Xu-Dong, et al.
Publicado: (2017)

Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
por: Sandrini, Giorgio, et al.
Publicado: (2017)

Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: A follow-up retrospective study of 152 patients
por: Zhang, Haifeng, et al.
Publicado: (2019)

Postherpetic Neuralgia and Trigeminal Neuralgia
por: Feller, L., et al.
Publicado: (2017)

Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil
por: Holle, Dagny, et al.
Publicado: (2013)

"Neuralgia trigeminal"/
por: Martínez Miranda, Roberto Oscar
Publicado: (2005)

Trigeminal neuralgia
por: Truini, Andrea
Publicado: (2015)

Trigeminal Neuralgia
por: Carleton, H. H.
Publicado: (1932)

Trigeminal Neuralgia
por: Yadav, Yad Ram, et al.
Publicado: (2017)

Trigeminal Neuralgia
Publicado: (1933)

For Trigeminal Neuralgia
Publicado: (1890)

Cannot write session to /tmp/vufind_sessions/sess_60smvotdo44l4tbd1otdin83b4